These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14737754)

  • 1. Lack of multiplicative transitivity in person trade-off responses.
    Schwarzinger M; Lanoë JL; Nord E; Durand-Zaleski I
    Health Econ; 2004 Feb; 13(2):171-81. PubMed ID: 14737754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The person trade-off method and the transitivity principle: an example from preferences over age weighting.
    Dolan P; Tsuchiya A
    Health Econ; 2003 Jun; 12(6):505-10. PubMed ID: 12759919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
    Robinson S
    Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences and person trade-offs: forcing consistency or inconsistency in health-related quality of life measures?
    Mansley EC; Elbasha EH
    Health Econ; 2003 Mar; 12(3):187-98. PubMed ID: 12605464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-method approach to measuring health-state valuations.
    Salomon JA; Murray CJ
    Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations.
    Ubel PA; Loewenstein G; Scanlon D; Kamlet M
    Health Policy; 1998 Jan; 43(1):33-44. PubMed ID: 10178799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-saving treatments and disabilities. Are all QALYs created equal?
    Ubel PA; Richardson J; Prades JL
    Int J Technol Assess Health Care; 1999; 15(4):738-48. PubMed ID: 10645115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia.
    Schulz MW; Chen J; Woo HH; Keech M; Watson ME; Davey PJ
    J Urol; 2002 Jul; 168(1):155-9. PubMed ID: 12050512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuing quality of life: results for New Zealand health professionals.
    Devlin N; Williams A
    N Z Med J; 1999 Mar; 112(1083):68-71. PubMed ID: 10210306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.
    Dale W; Basu A; Elstein A; Meltzer D
    Med Decis Making; 2008; 28(1):102-12. PubMed ID: 18057188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the person trade-off a valid method for allocating health care resources?
    Pinto Prades JL
    Health Econ; 1997; 6(1):71-81. PubMed ID: 9142532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the societal value of health care: what do we know about the person trade-off technique?
    Green C
    Health Econ; 2001 Apr; 10(3):233-43. PubMed ID: 11288189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does it matter who you are or what you gain? An experimental study of preferences for resource allocation.
    Schwappach DL
    Health Econ; 2003 Apr; 12(4):255-67. PubMed ID: 12652513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of order effects in person trade-off elicitations.
    Ubel PA; Richardson J; Baron J
    Health Policy; 2002 Aug; 61(2):189-99. PubMed ID: 12088891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.
    Grann VR; Jacobson JS; Sundararajan V; Albert SM; Troxel AB; Neugut AI
    Cancer J Sci Am; 1999; 5(5):283-92. PubMed ID: 10526669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.